Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Senti Biosciences (SNTI) Net Income towards Common Stockholders (2021 - 2025)

Senti Biosciences has reported Net Income towards Common Stockholders over the past 5 years, most recently at -$18.5 million for Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders changed N/A year-over-year to -$18.5 million; the TTM value through Dec 2025 reached -$65.5 million, down 25.55%, while the annual FY2025 figure was -$67.9 million, N/A changed from the prior year.
  • Net Income towards Common Stockholders for Q4 2025 was -$18.5 million at Senti Biosciences, down from -$18.1 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $21.7 million in Q3 2023 and troughed at -$28.9 million in Q3 2024.
  • A 5-year average of -$9.2 million and a median of -$11.2 million in 2024 define the central range for Net Income towards Common Stockholders.
  • Biggest five-year swings in Net Income towards Common Stockholders: plummeted 997692.87% in 2022 and later skyrocketed 1028.2% in 2023.
  • Year by year, Net Income towards Common Stockholders stood at -$3.9 million in 2021, then tumbled by 121.54% to -$8.5 million in 2022, then soared by 99.67% to -$28000.0 in 2023, then plummeted by 102992.86% to -$28.9 million in 2024, then surged by 35.78% to -$18.5 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for SNTI at -$18.5 million in Q4 2025, -$18.1 million in Q3 2025, and -$14.7 million in Q2 2025.